Valuation: Psychemedics Corporation

Market Cap 9.79M 8.79M 8.11M 7.36M 13.75M 930M 13.92M 97.28M 38.63M 487M 36.75M 35.97M 1.55B P/E 2023
-4.09x
P/E 2024 -7x
Enterprise Value 9.54M 8.56M 7.91M 7.17M 13.4M 906M 13.56M 94.79M 37.64M 475M 35.81M 35.04M 1.51B EV / Sales 2023
0.79x
EV / Sales 2024 0.68x
Free-Float
44.15%
Yield 2023
2.36%
Yield 2024 -
1 week-3.61%
Current month-3.61%
1 month-3.61%
3 months-3.61%
6 months+9.09%
Current year+50.00%
Current year 1.33
Extreme 1.33
2.7
1 year 1.33
Extreme 1.33
2.7
3 years 1.11
Extreme 1.11
3.93
5 years 1.11
Extreme 1.11
8.9
10 years 1.11
Extreme 1.11
27.99
Manager TitleAgeSince
Chief Executive Officer 59 2023-08-16
Director of Finance/CFO 36 2023-11-26
Corporate Officer/Principal 40 2023-09-20
Director TitleAgeSince
Director/Board Member 64 2021-03-15
Director/Board Member 58 2022-04-03
Director/Board Member 64 2022-08-11
Date Insider Type Main position Quantity % Market Cap. Importance
12/13/24
Powell Anderson Capital Partners
BuyCompany 159,700 2.7093%
12/10/24
Powell Anderson Capital Partners
BuyCompany 86,991 1.4758%
12/10/24 Sell

Director

320,708 5.4408%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-3.61%+14.29%-2.04% 15.26M
-1.51%-3.82%+10.53%+37.47% 117B
-3.29%-3.39%-3.83%+99.72% 97.42B
+1.46%+1.21%+113.72%+973.76% 59.22B
-0.80%+3.23%-5.94%+90.00% 29.03B
+0.38%+2.49%+20.14%+66.45% 26.86B
-0.16%+2.29%+34.56%+89.97% 26.69B
-2.57%-3.77%+21.22%+393.32% 21.1B
+0.59%+3.16%-17.78%-7.35% 20.61B
-0.13%-1.39%-5.43%+31.38% 16.94B
Average -0.62%-0.14%+18.15%+177.27% 41.44B
Weighted average by Cap. -1.15%-1.33%+21.40%+210.47%

Financials

2023 2024
Net sales 22.1M 19.83M 18.31M 16.61M 31.04M 2.1B 31.42M 220M 87.2M 1.1B 82.95M 81.17M 3.49B 19.68M 17.67M 16.31M 14.79M 27.65M 1.87B 27.99M 196M 77.68M 980M 73.89M 72.31M 3.11B
Net income -4.15M -3.73M -3.44M -3.12M -5.83M -395M -5.91M -41.27M -16.39M -207M -15.59M -15.26M -656M -1.86M -1.67M -1.54M -1.4M -2.61M -177M -2.65M -18.49M -7.34M -92.65M -6.99M -6.84M -294M
Net Debt 334K 300K 277K 251K 469K 31.73M 475K 3.32M 1.32M 16.63M 1.25M 1.23M 52.73M -251K -225K -208K -189K -353K -23.84M -357K -2.49M -990K -12.5M -942K -922K -39.63M
Projected Income Statement - Annual - Psychemedics Corporation
Logo Psychemedics Corporation
Psychemedics Corporation is a hair drug testing company. The Company provides testing services for the detection of drugs of abuse through the analysis of hair samples. Its testing methods utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. The Company customizes its enzyme immunoassay (EIA) procedures to drug test hair samples. It provides screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, phenylcyclohexyl piperidine (PCP), amphetamines (including ecstasy, eve, and Adderall), opiates (including heroin, hydrocodone, hydromorphone, oxycodone and codeine), synthetic cannabinoids (including K2, Spice, Blaze), benzodiazepines (Xanax, Valium, and Ativan), nicotine, Fentanyl, and alcohol. The Company markets its corporate drug testing services through its own sales force, distributors, and partners. It markets its home drug testing service, PDT-90, through the Internet.
Employees
101
  1. Stock Market
  2. Stocks
  3. PMDI Stock